Invention Grant
- Patent Title: Anti-EGFR combinations for treating tumors
-
Application No.: US16068338Application Date: 2017-01-06
-
Publication No.: US11136397B2Publication Date: 2021-10-05
- Inventor: Lixin Li
- Applicant: BIRDIE BIOPHARMACEUTICALS, INC.
- Applicant Address: KY Grand Cayman
- Assignee: BIRDIE BIOPHARMACEUTICALS, INC.
- Current Assignee: BIRDIE BIOPHARMACEUTICALS, INC.
- Current Assignee Address: KY Grand Cayman
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; David Diamond
- Priority: CN201610009256.8 20160107
- International Application: PCT/CN2017/070406 WO 20170106
- International Announcement: WO2017/118406 WO 20170713
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K31/437 ; A61K31/4985 ; A61K31/519 ; A61K31/4745 ; A61P35/00 ; A61K31/429 ; A61K31/522 ; A61K45/06 ; A61K39/00 ; A61K38/16
Abstract:
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.
Public/Granted literature
- US20190016808A1 ANTI-EGFR COMBINATIONS FOR TREATING TUMORS Public/Granted day:2019-01-17
Information query
